KASH PETER M 4
4 · Nile Therapeutics, Inc. · Filed Dec 23, 2008
Insider Transaction Report
Form 4
KASH PETER M
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2008-12-23+35,000→ 35,000 totalExercise: $0.93Exp: 2018-12-22→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]100% of the shares subject to the option shall vest and become exercisable on January 1, 2010.